Who owns Verona Pharma?

Verona Pharma is formerly owned by Sofinnova Partners, through Sofinnova Crossover Fund I, since 2019.

When did Sofinnova Partners acquire Verona Pharma?

Sofinnova Partners acquired Verona Pharma in 2019 and exited after 6 years.

Yes. Verona Pharma was exited in 2025 via Trade Sale.

Biotech·

UK·Exited 2025·Held 6yr

Verona Pharma is a healthcare company, headquartered in United Kingdom.

Entry

2019

Hold

6yr

Exit

2025

Est. EV

–

Most recent investor

2 ownership periods

HQUnited Kingdom

SectorHealthcare

Respiratory disease biotech. Acquired by Merck for $10B in July 2025 | Acquired by Merck (MSD) on October 7, 2025 for ~B (/ADS).

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Sofinnova Crossover Fund I

6 comparable biotech deals from other GPs

Exit details: type, year, MOIC (buyer on Pro)

Already a member? Sign in

Data refreshed weekly · Sourced from public filings